Abiopharma

🔍 ANGEL STEPHEN F (Executive)

Company: CSX CORP (CSX)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 185 shares of Phantom Stock (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: false | shares_owned_after: 2,387.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2

Footnotes:

• F1: Each unit of phantom stock is the economic equivalent of one share of Company common stock. Units of phantom stock become payable, in cash, consistent with the Reporting Person's distribution election made at the time of deferral.
• F2: By Trustee, CSX Corporation Executive Deferred Compensation Plan.